Drugs / un-adjuvanted influenza A(H1N1) vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01201902 Comparator | Oct → Dec 2009 | influenza | Green Cross Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | un-adjuvanted influenza A(H1N1) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01201902 ↗ |
| Modality | Vaccine | “Inactivated Split-virion Influenza A(H1N1) Vaccine” NCT01201902 ↗ |
| Route | Intramuscular | “Intramuscular on Day 0 and 21” NCT01201902 ↗ |